title: Up-regulation of fibroblast growth factor-binding protein, by beta-catenin during colon carcinogenesis.
abstract: Fibroblast growth factor-binding protein (FGF-BP) releases immobilized FGFs from the extracellular matrix and can function as an angiogenic switch molecule in cancer. Here we show that FGF-BP is up-regulated in early dysplastic lesions of the human colon that are typically associated with a loss of adenomatous polyposis coli and up-regulation of beta-catenin. In addition, FGF-BP expression is induced in dysplastic lesions in ApcMin/+ mice in parallel with the up-regulation of beta-catenin. Also, in cell culture studies FGF-BP is induced by beta-catenin through direct activation of the FGF-BP gene promoter. We conclude that FGF-BP is a target gene of beta-catenin.
authors.affiliation: Lombardi Cancer Center, Georgetown University, Washington, DC 20057, USA.
authors.forename: Ranjan
authors.initials: R
authors.lastname: Ray
authors.forename: Rafael
authors.initials: R
authors.lastname: Cabal-Manzano
authors.forename: Amy R
authors.initials: AR
authors.lastname: Moser
authors.forename: Todd
authors.initials: T
authors.lastname: Waldman
authors.forename: Laurie M
authors.initials: LM
authors.lastname: Zipper
authors.forename: Achim
authors.initials: A
authors.lastname: Aigner
authors.forename: Stephen W
authors.initials: SW
authors.lastname: Byers
authors.forename: Anna T
authors.initials: AT
authors.lastname: Riegel
authors.forename: Anton
authors.initials: A
authors.lastname: Wellstein
mesh_terms: D000236:Adenoma / Q000235:genetics / Q000378:metabolism; D000818:Animals; D002352:Carrier Proteins / Q000096:biosynthesis* / Q000235:genetics; D003110:Colonic Neoplasms / Q000235:genetics / Q000378:metabolism*; D003598:Cytoskeletal Proteins / Q000096:biosynthesis / Q000235:genetics / Q000502:physiology*; D015972:Gene Expression Regulation, Neoplastic / Q000187:drug effects; D006801:Humans; D036341:Intercellular Signaling Peptides and Proteins; D047908:Intracellular Signaling Peptides and Proteins; D018021:Lithium Chloride / Q000494:pharmacology; D051379:Mice; D008810:Mice, Inbred C57BL; D011401:Promoter Regions, Genetic; D012333:RNA, Messenger / Q000096:biosynthesis / Q000235:genetics; D015534:Trans-Activators / Q000096:biosynthesis / Q000235:genetics / Q000502:physiology*; D014162:Transfection; D015854:Up-Regulation / Q000187:drug effects; D051176:beta Catenin
chemical_list: C495270:CTNNB1 protein, human; C495267:CTNNB1 protein, mouse; D002352:Carrier Proteins; D003598:Cytoskeletal Proteins; C489453:Fgfbp1 protein, mouse; D036341:Intercellular Signaling Peptides and Proteins; D047908:Intracellular Signaling Peptides and Proteins; D012333:RNA, Messenger; D015534:Trans-Activators; D051176:beta Catenin; C070699:FGFBP1 protein, human; D018021:Lithium Chloride